Literature DB >> 9565052

The psychosocial impact of macular degeneration.

R A Williams1, B L Brody, R G Thomas, R M Kaplan, S I Brown.   

Abstract

BACKGROUND: Age-related macular degeneration (AMD), the leading cause of irreversible blindness and low vision among the elderly, has not been well studied with regard to its impact on daily life. This study was designed to demonstrate the impact of AMD on quality of life, emotional distress, and functional level. PARTICIPANTS: The study sample consisted of 86 elderly adults (average age, 79 years) with AMD who were legally blind in at least 1 eye. Participants completed a battery of measures that included the Quality of Well-being Scale, the Instrumental Activities of Daily Living index, self-rated general health status, and the Profile of Mood States.
RESULTS: Persons with AMD experienced significant reductions in key aspects of daily life. Their ratings for quality of life (average Quality of Well-being Scale score=0.581) and emotional distress (average Profile of Mood States total score=65.36) were significantly worse than those for similarly aged community adults and were comparable with those reported by people with chronic illnesses (eg, arthritis, chronic obstructive pulmonary disease, acquired immunodeficiency syndrome, and bone marrow transplants). Patients with AMD were also more likely than a national sample of elderly individuals to need help with daily activities. Visual acuity was related to ability to carry out daily activities (Instrumental Activities of Daily Living, r=0.28, P=.008). Quality of life ratings were significantly related to the ability to carry out daily activities (r=-0.38, P=.001), self-rated general health status (r=-0.21, P=.05), and emotional distress (Profile of Mood States total score, r=-0.25, P=.02). Individuals with a shorter period of perceived vision loss were more likely to report high levels of emotional distress (r=-0.24, P=.03) than those with a longer period of perceived vision loss. Further, those who were blind in 1 eye were even more significantly distressed than those who were blind in both eyes.
CONCLUSIONS: Elderly persons with AMD causing legal blindness in 1 or both eyes have significant emotional distress and profoundly reduced quality of life and need help with key daily activities.

Entities:  

Mesh:

Year:  1998        PMID: 9565052     DOI: 10.1001/archopht.116.4.514

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  110 in total

1.  Impact of age related macular degeneration on quality of life.

Authors:  J B Hassell; E L Lamoureux; J E Keeffe
Journal:  Br J Ophthalmol       Date:  2006-05       Impact factor: 4.638

2.  Design of an individualised measure of the impact of macular disease on quality of life (the MacDQoL).

Authors:  Jan Mitchell; Clare Bradley
Journal:  Qual Life Res       Date:  2004-08       Impact factor: 4.147

3.  Computer use among patients with age-related macular degeneration.

Authors:  Barbara L Brody; Linda C Field; Anne-Catherine Roch-Levecq; Colin Depp; Steven D Edland; Lilit Minasyan; Stuart I Brown
Journal:  Ophthalmic Epidemiol       Date:  2012-08       Impact factor: 1.648

Review 4.  Emerging roles for nuclear receptors in the pathogenesis of age-related macular degeneration.

Authors:  Goldis Malek; Eleonora M Lad
Journal:  Cell Mol Life Sci       Date:  2014-08-26       Impact factor: 9.261

5.  Geographic variation in the prevalence of macular disease among elderly medicare beneficiaries in Kansas.

Authors:  Carol Ann Holcomb; Mu-Chuan Lin
Journal:  Am J Public Health       Date:  2005-01       Impact factor: 9.308

Review 6.  Economic cost of age-related macular degeneration: a review of recent research.

Authors:  Kathleen M Ke; Usha Chakravarthy; Ciaran O'Neill
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

7.  Applying theories and interventions from behavioral medicine to understand and reduce visual field variability in patients with vision loss.

Authors:  Collin Rozanski; Jennifer A Haythornthwaite; Gislin Dagnelie; Ava K Bittner
Journal:  Med Hypotheses       Date:  2014-05-09       Impact factor: 1.538

8.  Enhanced low vision rehabilitation for people with age related macular degeneration: a randomised controlled trial.

Authors:  B C Reeves; R A Harper; W B Russell
Journal:  Br J Ophthalmol       Date:  2004-11       Impact factor: 4.638

9.  Vision-related quality of life: 12-month aflibercept treatment in patients with treatment-resistant neovascular age-related macular degeneration.

Authors:  Meidong Zhu; Wijeyanthy Wijeyakumar; Adil R Syed; Nichole Joachim; Thomas Hong; Geoffrey K Broadhead; Haitao Li; Kehui Luo; Andrew Chang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-08-30       Impact factor: 3.117

10.  Depression in Age-Related Macular Degeneration.

Authors:  Robin Casten; Barry Rovner
Journal:  J Vis Impair Blind       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.